Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
University of Pittsburgh
University of Pittsburgh
Brigham and Women's Hospital
Ruijin Hospital
University of Texas Southwestern Medical Center
Vanderbilt-Ingram Cancer Center
Vanderbilt-Ingram Cancer Center
Grupo Español de Tratamiento de Tumores de Cabeza y Cuello